Applications published 10 June 2009

Self-preserved aqueous pharmaceutical compsns
Alcon Research 2066300*

Injectable pharmaceutical nimesulide solutions
Pharmatex 2066301*

Stabilising compsn for antibiotics and methods of use
Taro Pharmaceuticals North America 2066302*

Method and system for treatment of eating disorders
Plensat 2066303*

Systems, methods and compsns for treatment and use of a palatal patch
Dental Biotechnology 2066304*

Polymer matrix, method for its production and its use
KIST-Europe Forschungsgesellschaft 2066305*

Process for preparing granules of hydrophilic vitamins
BASF 2066306*

Rapidly disintegrating dosage form
Pfizer 2066307*

Multi-core solid dosage form comprising a transparent coating between said cores
McNeil-PPC 2066308*

An oral pharmaceutical compsn
Sigmoid Pharma 2066309*

Emulsions comprising rubber arabicum
Mitival 2066310*

Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
GPC Biotech 2066311*

• Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases
Centre National de la Recherche Scientifique (CNRS) 2066312*

• Topical compsns
ISW Group 2066313*

• Use of theogallin for the treatment of mental concentration disorders, depression and dementia
Plantextract 2066314*

• Treatment of pain using satraplatin
GPC Biotech 2066315*

• Azetidine and azetidone derivatives in treating pain and disorders of lipid metabolism
Schering 2066316*

• Use of ion channel modulators in the prophylaxis and treatment of inflammatory and immunological diseases
Lectus Therapeutics 2066317*

• Oxindole derivatives as anticancer agents
F Hoffmann-La Roche 2066318*

• Benzotriazole kinase modulators
F Hoffmann-La Roche 2066319*

• Methods and compsns for treating lymphoma and myeloma
IRM 2066320*

• Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
Lutonix 2066321*

• Hydrogenated pyrido [4,3-B] indoles such as dimebon for treating canine cognitive dysfunction syndrome
Medivation Neurology 2066322*

• Pharmaceutical compsns comprising combinations of an AMPA/Kainate antagonistic compound and an inhibitor of a multi-drug resistance protein
NeuroSearch 2066323*

• Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors
Cephalon 2066324*

• Pharmaceutical compsns of aripiprazole
Zysis 2066325*

• Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
Enanta Pharmaceuticals 2066326*

• Histone deacetylase inhibitors with combined activity on class-1 and class-IIB histone deactylases in combination with proteasome inhibitors
Janssen Pharmaceutica 2066327*

• Combinations of class-1 specific histone deacetylase inhibitors with proteasome inhibitors
Janssen Pharmaceutica 2066328*

• Synthesis, methods of using, and compsns of cycloalkylmethylamines
Revivia Pharmaceuticals 2066329*

• Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
Altergon 2066330*

• Methods of treating pain with reduced nausea and vomiting
Limerick Biopharma 2066331*

• Flu vaccine admixture of mannan and flu antigen
The Macfarlane Burnett Institute for Medical Research and Public Health 2066332*

• Valerian extract preparation
Finzelberg 2066333*

• RNAI methods and compsns for stimulating proliferation of cells with adherent junctions
TissueTech 2066334*

• Cytokine signalling
Case Western Reserve University 2066335*

• Use of pegylated IL-10 to treat cancer
Schering 2066336*

• Use of exendins, exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
Amylin Pharmaceuticals; Eli Lilly 2066337*

• Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system
Universita" Degli Studi Milano 2066338*

• Compsns and methods of enhancing immune responses
The Board of Trustees of the University of Arkansas 2066339*

• Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
Pfizer Products 2066340*

• Method of eliciting or inducing an immune response
CSL; The University of Melbourne 2066341*

• Pestivirus mutant for use in a vaccine
Intervet International 2066342*

• Novel neutralising immunogen (NIMIV) of rhinovirus and its use for vaccine applications
Sanofi Pasteur Biologics 2066343*

• Vaccine
GlaxoSmithKline Biologicals 2066344*

• Making influenza virus vaccines without using eggs
Novartis 2066345*

• Alphavirus replicon particles encoding IL-12 as immunological adjuvants
AlphaVax 2066346*

• Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases
Cytos Biotechnology 2066347*

• Compsns and methods for enhancing an adjuvant
Alexion Pharmaceuticals; Stichting Katholieke Universiteit 2066348*

• Humanised anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
MedImmune 2066349*

• Stabilised antibody formulations and uses thereof
MedImmune 2066350*

• Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
Braincells 2066355*

• Cyclopentane derivatives as anti-glaucoma agents
Allergan 2066615*

• Process for the production of aromatic amines in the presence of a palladium complex comprising a ferrocenyl bisphosphine ligand
Syngenta Participations 2066617*

• Process for preparing boaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors
Novartis 2066618*

• Soluble epoxide hydrolase inhibitors
Arete Therapeutics 2066619*

• Di-aromatic substituted amides as inhibitors for GLYT1
F Hoffmann-La Roche 2066620*

• Synthesis, polymorphs, and pharmaceutical formulation of a FAAH inhibitor
NV Organon 2066621*

• Process for preparing hexamethylene-biscyanoguanidine and chlorhexidine
Evonik Degussa 2066622*

• Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof
Otsuka Pharmaceutical 2066623*

• Improved method of production of 9-cis-retinoic acid
DSM Fine Chemicals Austria 2066624*

• Apparatus and method for making a peroxycarboxylic acid
Ecolab 2066625*

• Azetidine derivatives as muscarinic receptor antagonists
Pfizer 2066626*

• Novel minor groove binders
The University of Strathclyde 2066627*

• 2-phenyl-indoles as prostaglandin D2 receptor antagonists
Sanofi-Aventis 2066628*

• Piperidine derivatives
Pfizer 2066630*

• Pyridine borane complexes
BASF 2066631*

• Benzophenone derivatives useful for inhibiting formation of microtubule
Chong Kun Dang Pharmaceutical 2066632*

• Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist and/or antagonist biological activity
Allergan 2066633*

• 4-phenoxy-nicotine acid derivatives and use thereof as PPAR modulators
Bayer Healthcare 2066634*

• 2-phenoxy nicotine acid derivative and use thereof
Bayer Schering Pharma 2066635*